News Roswell Park Study: Inhibiting Regulator Protein Can Make Aggressive Prostate Cancers More Vulnerable
News First-in-Human Clinical Trial Evaluates Bispecific Antibody for Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
News MimiVax and Roswell Park Open Phase 2 Trial of SurVaxM for Patients with Metastatic Neuroendocrine Tumors
News Clinical Trial Hopes to Boost Survival Rates with Personalized Treatment for Extensive-Stage Small Cell Lung Cancer